- Allotex Announces New Investor and Expansion of Production Facilities USA - English USA - English
- "Street Fighter™ 6" Panel Announced for December 2nd at Los Angeles Comic Con; The Music of Street Fighter 6: A Special Look at the Video Game
- Lawmato relaunches its virtual consultation app with enhanced features
The REDUCE LAP-HF II trial is the world's first phase III trial to evaluate safety and efficacy of an atrial shunt in heart failure patients. The study of 626 patients previously identified a responder group, representing half of all study participants, who experienced a significant reduction in heart failure events and an improvement in quality of life at one year. The two-year results confirmed that this benefit was sustained in this group.
More on Boston Chron
- Steeped in Tradition: USAA Kicks Off 124th Army-Navy Game Celebrations in a Massive Way, Honoring 250th Anniversary of the Boston Tea Party
- Putnam Investments Announces 19(a) Notices for Closed-End Funds
- InventHelp Inventor Develops New Tool Belt for Cedar Shingles & Cedar Shingling Tools (BKC-128)
- Essential Speech and ABA Therapy to Expand Autism Services for a Growing Community
- Local Advocacy Organization, Keep Boston Goat Free, Celebrates Goat Ban in City of Boston
Finn Gustafsson, MD, Professor of Cardiology at University of Copenhagen commented on the findings: "The two-year REDUCE LAP-HF II findings demonstrate the longer-term safety of the Corvia Atrial Shunt and support what we observed at one year, that in properly selected patients, atrial shunting appears to have lasting clinical benefit in the reduction of heart failure events."
Sanjiv Shah, MD from Northwestern University Feinberg School of Medicine and co-principal investigator for the trial added: "The 24-month results from the REDUCE LAP-HF II trial provide further assurance of the safety and efficacy of the Corvia Atrial Shunt." He expressed optimism that this device has potential to deliver significant long-term benefits to a large proportion of heart failure patients.
Jan Komtebedde, Chief Medical Officer at Corvia Medical said: "We are excited about the two-year outcomes in the responder group as they provide strong evidence that we have successfully identified those heart failure patients who will benefit most from atrial shunting." He added that they are currently recruiting patients into RESPONDER-HF study - a confirmatory, randomized, sham controlled trial - which will provide additional evidence required to make this therapy available to a broader patient population.
Filed Under: Business
Latest on Boston Chron
- Empowering Voices: Houston's Black Authors Illuminate the Blockchain World with 'Chain Reaction'
- Unlocking the Magic of Miami Beach
- Introducing Scuba Diving Industry Magazine
- Five-year Contract Ratified by Boston Police Patrolmen's Association
- The Five Pillars of Success Pillar One Strengths Outlined by Rosann Santos CPC
- Pitch Black Appoints New Chief People Officer
- SmartBear Wins Winter 2023 Digital Innovator Award from Intellyx
- Mayor Michelle Wu announces five-year contract ratified by Boston Police Patrolmen's Association, codifying operational reforms and fair compensation
- Tanisha Deleon Named Deputy Director of Youth Options Unlimited Boston
- Emmy Award Winning Journalist Joins Prominent Haddonfield Real Estate Agency
- John Hancock Investment Management celebrates 50-year anniversary of Bond Fund
- Shields Health Solutions Awards Two Resident Research Grants to Advance Health System Specialty Pharmacy
- Founder Brings Inaugural Event To Braselton Georgia At Legendary Resort and Winery
- Projections Show HIV Global Markets for Diagnostics and Therapeutics to Hit $39.3 Billion by 2028, BCC Research Reveals
- HBCUs Among Groups Heading to The Bahamas for Track & Field Competition in March 2024
- Noble World Foundation Proposes UN Security Council Reform to Foster Global Peace
- Massachusetts: Governor Healey and Other Leaders of the Reproductive Freedom Alliance Urge Federal Government to Require Health Plan Coverage for All Contraception
- India Fest 2024 on Jan 27, 2024 at KY Expo Center
- Boston: Latest Updates from the Mayor's Office of Housing: December 1, 2023
- Massachusetts: Press Statement Governor Healey, Secretary Santiago Issue Statement on Passing of Staff Sgt. Jacob Galliher